Surgical and aesthetic outcome, quality of life, and cost-effectiveness of keloid treatment
Completed
- Conditions
- keloid
- Registration Number
- NL-OMON22731
- Lead Sponsor
- Erasmus University Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 26
Inclusion Criteria
Keloid patients, keloid >1x1 cm, 18-75 yr old, full mental competence, sufficient knowledge of Dutch or English language, keloid suitable for primary closure after excision.
Exclusion Criteria
Hypertrophic scars, keloids < 1yr old, burn scars, pregnancy, use of chemotherapy, chronic use of corticosteroids or immonosuppressors, life expectancy < 1 yr, hypersensitivity for lidocaine, epinephrine, triamcenolone acetonide
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient Observer Scar Assessment Scals score.
- Secondary Outcome Measures
Name Time Method Volume reduction, Skindex-29, SF-36, ED-5Q, appearance of adverse reactions, patient statisfaction.